FCMI
XLRN

Foresite Capital Management III’s Acceleron Pharma XLRN Stock Holding History

Foresite Capital Management III’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100,000
Closed -$4.88M – 24
2015
Q4 		$4.88M Buy
+100,000
New +$3.6M 4.32% 10

Foresite Capital Management III's XLRN Position: Q4 2021 in Review

Foresite Capital Management III sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 108,630 shares — an estimated $18.7M sold.

Foresite Capital Management III first reported a position in XLRN in Q4 2015 and held it in 22 quarters. The position peaked at $18.7M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Foresite Capital Management III reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Foresite Capital Management III sold 108,630 Acceleron Pharma shares in Q4 2021, an estimated $18.7M.
  • Foresite Capital Management III first reported a position in Acceleron Pharma in Q4 2015 and held it in 22 quarters.
  • Foresite Capital Management III's Acceleron Pharma position peaked at $18.7M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Foresite Capital Management III's 13F filing for Q4 2021, filed 11 Feb 2022.